114 related articles for article (PubMed ID: 11685124)
1. Provocative effects of the immunosuppressants rapamycin, tacrolimus, and dexamethasone on pneumonitis in contrast to the anti- pneumonitis effects of mycophenolate mofetil.
Oz HS; Hughes WT; Varilek G
Transplantation; 2001 Oct; 72(8):1464-5. PubMed ID: 11685124
[No Abstract] [Full Text] [Related]
2. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone.
Oz HS; Hughes WT
J Infect Dis; 1997 Apr; 175(4):901-4. PubMed ID: 9086147
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function.
Jeanmart H; Malo O; Carrier M; Nickner C; Desjardins N; Perrault LP
J Heart Lung Transplant; 2002 Sep; 21(9):990-8. PubMed ID: 12231370
[TBL] [Abstract][Full Text] [Related]
4. Similar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens.
Girman P; Lipar K; Koznarova R; Boucek P; Kriz J; Kocik M; Havrdova T; Adamec M; Saudek F
Transplant Proc; 2010; 42(6):1999-2002. PubMed ID: 20692391
[TBL] [Abstract][Full Text] [Related]
5. Clinically significant drug interactions with new immunosuppressive agents.
Mignat C
Drug Saf; 1997 Apr; 16(4):267-78. PubMed ID: 9113494
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration.
Waller JR; Brook NR; Bicknell GR; Murphy GJ; Nicholson ML
Transplant Proc; 2005; 37(1):164-6. PubMed ID: 15808582
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results.
Kaczmarek I; Zaruba MM; Beiras-Fernandez A; Reimann R; Nickel T; Grinninger C; Sadoni S; Hagl C; Meiser B
J Heart Lung Transplant; 2013 Mar; 32(3):277-84. PubMed ID: 23415313
[TBL] [Abstract][Full Text] [Related]
8. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.
Dean PG; Lund WJ; Larson TS; Prieto M; Nyberg SL; Ishitani MB; Kremers WK; Stegall MD
Transplantation; 2004 May; 77(10):1555-61. PubMed ID: 15239621
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients.
Guo YW; Gu HY; Abassa KK; Lin XY; Wei XQ
World J Gastroenterol; 2016 Jun; 22(24):5616-22. PubMed ID: 27350740
[TBL] [Abstract][Full Text] [Related]
10. Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation.
Morales JM
Kidney Int Suppl; 2002 Dec; (82):S81-7. PubMed ID: 12410861
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
Brazelton TR; Morris RE
Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398
[TBL] [Abstract][Full Text] [Related]
12. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
Pratap B; Abraham G; Srinivas CN; Bhaskar S
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
[TBL] [Abstract][Full Text] [Related]
14. Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.
van Gelder T; ter Meulen CG; Hené R; Weimar W; Hoitsma A
Transplantation; 2003 Mar; 75(6):788-91. PubMed ID: 12660502
[TBL] [Abstract][Full Text] [Related]
15. Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology and function in single kidney rats submitted to ischemia and reperfusion.
Dias PH; Oliveira GA; Dias FG; Gomes Rde P; Tambara Filho R; Fraga Rd
Acta Cir Bras; 2015 Feb; 30(2):127-33. PubMed ID: 25714692
[TBL] [Abstract][Full Text] [Related]
16. The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients.
Powell N; Till S; Bungre J; Corrigan C
J Allergy Clin Immunol; 2001 Dec; 108(6):915-7. PubMed ID: 11742267
[TBL] [Abstract][Full Text] [Related]
17. Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation.
Chinnakotla S; Davis GL; Vasani S; Kim P; Tomiyama K; Sanchez E; Onaca N; Goldstein R; Levy M; Klintmalm GB
Liver Transpl; 2009 Dec; 15(12):1834-42. PubMed ID: 19938137
[TBL] [Abstract][Full Text] [Related]
18. Nocardial infection in a renal transplant recipient on tacrolimus and mycophenolate mofetil.
Magee CC; Halligan RD; Milford EL; Sayegh MH
Clin Nephrol; 1999 Jul; 52(1):44-6. PubMed ID: 10442495
[TBL] [Abstract][Full Text] [Related]
19. Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction.
Wilasrusmee C; Da Silva M; Singh B; Siddiqui J; Bruch D; Kittur S; Wilasrusmee S; Kittur DS
Clin Transplant; 2003; 17 Suppl 9():6-12. PubMed ID: 12795661
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus and mycophenolate mofetil after liver transplantation.
Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
